Global Touch Activated Phlebotomy Device market size is predicted to grow from US$ 244 million in 2025 to US$ 581 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.

Global Touch Activated Phlebotomy Device Market Trends, Growth | CAGR Of 12.8%

The global Touch Activated Phlebotomy Device market size is predicted to grow from US$ 244 million in 2025 to US$ 581 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032. Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%. As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency?especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, ?safe phlebotomy? is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service?expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities. Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital. Demand is shifting from ?usable? to ?controllable, traceable, and standardized.? Providers increasingly focus on the entire pre-analytical quality chain?patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem. Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability?forming the foundation for brand trust and long-term institutional partnerships. Infinity Market Research newest research report, the ?Touch Activated Phlebotomy Device Industry Forecast? looks at past sales and reviews total world Touch Activated Phlebotomy Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Touch Activated Phlebotomy Device sales for 2026 through 2032. With Touch Activated Phlebotomy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Touch Activated Phlebotomy Device industry. This Insight Report provides a comprehensive analysis of the global Touch Activated Phlebotomy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Touch Activated Phlebotomy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Touch Activated Phlebotomy Device market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Touch Activated Phlebotomy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Touch Activated Phlebotomy Device. This report presents a comprehensive overview, market shares, and growth opportunities of Touch Activated Phlebotomy Device market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Peripheral Venous Phlebotomy &nbsp;&nbsp;&nbsp; Central Line Sampling Support &nbsp;&nbsp;&nbsp; Other &nbsp;&nbsp;&nbsp; Segmentation by Needlestick: &nbsp;&nbsp;&nbsp; Passive Safety &nbsp;&nbsp;&nbsp; Active Safet &nbsp;&nbsp;&nbsp; Segmentation by Safety Mechanism: &nbsp;&nbsp;&nbsp; Passive/Auto-Engage &nbsp;&nbsp;&nbsp; User-Activated Mechanisms &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Diagnostics/Reference Labs &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; BD &nbsp;&nbsp;&nbsp; Greiner Bio-One &nbsp;&nbsp;&nbsp; Terumo &nbsp;&nbsp;&nbsp; Nipro &nbsp;&nbsp;&nbsp; B. Braun &nbsp;&nbsp;&nbsp; Sarstedt &nbsp;&nbsp;&nbsp; Cardinal Health &nbsp;&nbsp;&nbsp; Medline &nbsp;&nbsp;&nbsp; ICU Medical Key Questions Addressed in this Report What is the 10-year outlook for the global Touch Activated Phlebotomy Device market? What factors are driving Touch Activated Phlebotomy Device market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Touch Activated Phlebotomy Device market opportunities vary by end market size? How does Touch Activated Phlebotomy Device break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Touch Activated Phlebotomy Device Annual Sales 2021-2032 &nbsp;2.1.2 World Current & Future Analysis for Touch Activated Phlebotomy Device by Geographic Region, 2021, 2025 & 2032 &nbsp;2.1.3 World Current & Future Analysis for Touch Activated Phlebotomy Device by Country/Region, 2021, 2025 & 2032 &nbsp;2.2 Touch Activated Phlebotomy Device Segment by Type &nbsp;2.2.1 Peripheral Venous Phlebotomy &nbsp;2.2.2 Central Line Sampling Support &nbsp;2.2.3 Other &nbsp;2.2.4 Touch Activated Phlebotomy Device Sales by Type &nbsp;2.2.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026) &nbsp;2.2.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Type (2021-2026) &nbsp;2.2.4.3 Global Touch Activated Phlebotomy Device Sale Price by Type (2021-2026) &nbsp;2.3 Touch Activated Phlebotomy Device Segment by Needlestick &nbsp;2.3.1 Passive Safety &nbsp;2.3.2 Active Safet &nbsp;2.3.3 Touch Activated Phlebotomy Device Sales by Needlestick &nbsp;2.3.3.1 Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick (2021-2026) &nbsp;2.3.3.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Needlestick (2021-2026) &nbsp;2.3.3.3 Global Touch Activated Phlebotomy Device Sale Price by Needlestick (2021-2026) &nbsp;2.4 Touch Activated Phlebotomy Device Segment by Safety Mechanism &nbsp;2.4.1 Passive/Auto-Engage &nbsp;2.4.2 User-Activated Mechanisms &nbsp;2.4.3 Other &nbsp;2.4.4 Touch Activated Phlebotomy Device Sales by Safety Mechanism &nbsp;2.4.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism (2021-2026) &nbsp;2.4.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Safety Mechanism (2021-2026) &nbsp;2.4.4.3 Global Touch Activated Phlebotomy Device Sale Price by Safety Mechanism (2021-2026) &nbsp;2.5 Touch Activated Phlebotomy Device Segment by Application &nbsp;2.5.1 Hospitals &nbsp;2.5.2 Diagnostics/Reference Labs &nbsp;2.5.3 Other &nbsp;2.5.4 Touch Activated Phlebotomy Device Sales by Application &nbsp;2.5.4.1 Global Touch Activated Phlebotomy Device Sale Market Share by Application (2021-2026) &nbsp;2.5.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Application (2021-2026) &nbsp;2.5.4.3 Global Touch Activated Phlebotomy Device Sale Price by Application (2021-2026) 3 Global by Company &nbsp;3.1 Global Touch Activated Phlebotomy Device Breakdown Data by Company &nbsp;3.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Company (2021-2026) &nbsp;3.1.2 Global Touch Activated Phlebotomy Device Sales Market Share by Company (2021-2026) &nbsp;3.2 Global Touch Activated Phlebotomy Device Annual Revenue by Company (2021-2026) &nbsp;3.2.1 Global Touch Activated Phlebotomy Device Revenue by Company (2021-2026) &nbsp;3.2.2 Global Touch Activated Phlebotomy Device Revenue Market Share by Company (2021-2026) &nbsp;3.3 Global Touch Activated Phlebotomy Device Sale Price by Company &nbsp;3.4 Key Manufacturers Touch Activated Phlebotomy Device Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Touch Activated Phlebotomy Device Product Location Distribution &nbsp;3.4.2 Players Touch Activated Phlebotomy Device Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Touch Activated Phlebotomy Device by Geographic Region &nbsp;4.1 World Historic Touch Activated Phlebotomy Device Market Size by Geographic Region (2021-2026) &nbsp;4.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Geographic Region (2021-2026) &nbsp;4.1.2 Global Touch Activated Phlebotomy Device Annual Revenue by Geographic Region (2021-2026) &nbsp;4.2 World Historic Touch Activated Phlebotomy Device Market Size by Country/Region (2021-2026) &nbsp;4.2.1 Global Touch Activated Phlebotomy Device Annual Sales by Country/Region (2021-2026) &nbsp;4.2.2 Global Touch Activated Phlebotomy Device Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Touch Activated Phlebotomy Device Sales Growth &nbsp;4.4 APAC Touch Activated Phlebotomy Device Sales Growth &nbsp;4.5 Europe Touch Activated Phlebotomy Device Sales Growth &nbsp;4.6 Middle East & Africa Touch Activated Phlebotomy Device Sales Growth 5 Americas &nbsp;5.1 Americas Touch Activated Phlebotomy Device Sales by Country &nbsp;5.1.1 Americas Touch Activated Phlebotomy Device Sales by Country (2021-2026) &nbsp;5.1.2 Americas Touch Activated Phlebotomy Device Revenue by Country (2021-2026) &nbsp;5.2 Americas Touch Activated Phlebotomy Device Sales by Type (2021-2026) &nbsp;5.3 Americas Touch Activated Phlebotomy Device Sales by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Touch Activated Phlebotomy Device Sales by Region &nbsp;6.1.1 APAC Touch Activated Phlebotomy Device Sales by Region (2021-2026) &nbsp;6.1.2 APAC Touch Activated Phlebotomy Device Revenue by Region (2021-2026) &nbsp;6.2 APAC Touch Activated Phlebotomy Device Sales by Type (2021-2026) &nbsp;6.3 APAC Touch Activated Phlebotomy Device Sales by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Touch Activated Phlebotomy Device by Country &nbsp;7.1.1 Europe Touch Activated Phlebotomy Device Sales by Country (2021-2026) &nbsp;7.1.2 Europe Touch Activated Phlebotomy Device Revenue by Country (2021-2026) &nbsp;7.2 Europe Touch Activated Phlebotomy Device Sales by Type (2021-2026) &nbsp;7.3 Europe Touch Activated Phlebotomy Device Sales by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Touch Activated Phlebotomy Device by Country &nbsp;8.1.1 Middle East & Africa Touch Activated Phlebotomy Device Sales by Country (2021-2026) &nbsp;8.1.2 Middle East & Africa Touch Activated Phlebotomy Device Revenue by Country (2021-2026) &nbsp;8.2 Middle East & Africa Touch Activated Phlebotomy Device Sales by Type (2021-2026) &nbsp;8.3 Middle East & Africa Touch Activated Phlebotomy Device Sales by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device &nbsp;10.3 Manufacturing Process Analysis of Touch Activated Phlebotomy Device &nbsp;10.4 Industry Chain Structure of Touch Activated Phlebotomy Device 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Touch Activated Phlebotomy Device Distributors &nbsp;11.3 Touch Activated Phlebotomy Device Customer 12 World Forecast Review for Touch Activated Phlebotomy Device by Geographic Region &nbsp;12.1 Global Touch Activated Phlebotomy Device Market Size Forecast by Region &nbsp;12.1.1 Global Touch Activated Phlebotomy Device Forecast by Region (2027-2032) &nbsp;12.1.2 Global Touch Activated Phlebotomy Device Annual Revenue Forecast by Region (2027-2032) &nbsp;12.2 Americas Forecast by Country (2027-2032) &nbsp;12.3 APAC Forecast by Region (2027-2032) &nbsp;12.4 Europe Forecast by Country (2027-2032) &nbsp;12.5 Middle East & Africa Forecast by Country (2027-2032) &nbsp;12.6 Global Touch Activated Phlebotomy Device Forecast by Type (2027-2032) &nbsp;12.7 Global Touch Activated Phlebotomy Device Forecast by Application (2027-2032) 13 Key Players Analysis &nbsp;13.1 BD &nbsp;13.1.1 BD Company Information &nbsp;13.1.2 BD Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.1.3 BD Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.1.4 BD Main Business Overview &nbsp;13.1.5 BD Latest Developments &nbsp;13.2 Greiner Bio-One &nbsp;13.2.1 Greiner Bio-One Company Information &nbsp;13.2.2 Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.2.4 Greiner Bio-One Main Business Overview &nbsp;13.2.5 Greiner Bio-One Latest Developments &nbsp;13.3 Terumo &nbsp;13.3.1 Terumo Company Information &nbsp;13.3.2 Terumo Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.3.3 Terumo Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.3.4 Terumo Main Business Overview &nbsp;13.3.5 Terumo Latest Developments &nbsp;13.4 Nipro &nbsp;13.4.1 Nipro Company Information &nbsp;13.4.2 Nipro Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.4.3 Nipro Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.4.4 Nipro Main Business Overview &nbsp;13.4.5 Nipro Latest Developments &nbsp;13.5 B. Braun &nbsp;13.5.1 B. Braun Company Information &nbsp;13.5.2 B. Braun Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.5.3 B. Braun Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.5.4 B. Braun Main Business Overview &nbsp;13.5.5 B. Braun Latest Developments &nbsp;13.6 Sarstedt &nbsp;13.6.1 Sarstedt Company Information &nbsp;13.6.2 Sarstedt Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.6.3 Sarstedt Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.6.4 Sarstedt Main Business Overview &nbsp;13.6.5 Sarstedt Latest Developments &nbsp;13.7 Cardinal Health &nbsp;13.7.1 Cardinal Health Company Information &nbsp;13.7.2 Cardinal Health Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.7.3 Cardinal Health Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.7.4 Cardinal Health Main Business Overview &nbsp;13.7.5 Cardinal Health Latest Developments &nbsp;13.8 Medline &nbsp;13.8.1 Medline Company Information &nbsp;13.8.2 Medline Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.8.3 Medline Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.8.4 Medline Main Business Overview &nbsp;13.8.5 Medline Latest Developments &nbsp;13.9 ICU Medical &nbsp;13.9.1 ICU Medical Company Information &nbsp;13.9.2 ICU Medical Touch Activated Phlebotomy Device Product Portfolios and Specifications &nbsp;13.9.3 ICU Medical Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.9.4 ICU Medical Main Business Overview &nbsp;13.9.5 ICU Medical Latest Developments 14 Research Findings and Conclusion

Report	Global Touch Activated Phlebotomy Device Market Size, Share and Analysis Report 2026-2032
Selected License	Multi ID: ILR4738

Buyer Information

Order Summary